HomeMarkets Markets In first test for base editing, Verve’s one-time treatment lowers cholesterol levels in patients By news November 12, 2023 0 278 FacebookTwitterPinterestWhatsApp Verve Therapeutics said Sunday that the first 10 people to receive a one-time treatment powered by a form of CRISPR called base editing showed …This post was originally published on this site Share FacebookTwitterPinterestWhatsApp Subscribe Login Notify of new follow-up comments new replies to my comments Please login to comment 0 Comments Inline Feedbacks View all comments Stay Connected156,242FansLike396,312FollowersFollow2,340SubscribersSubscribe Latest Articles Biotech The Second Trump White House Could Drastically Reshape Infectious Disease Research. Here’s What’s at Stake. Top Trades PhilStockWorld Top Trade Alert – Jan 15, 2025 – Bank OZK (OZK) Markets Safety advocates fear Tesla will face less accountability for car crashes under Trump Markets Core inflation rate slows to 3.2% in December, less than expected Markets Germany’s economy shrank for the second consecutive year in 2024 Markets The Second Trump White House Could Drastically Reshape Infectious Disease Research. Here’s What’s at Stake. Markets T Minus 5 – CPI, Beige Book and the Beginning of Earnings Markets Trump’s plan for a strategic bitcoin reserve could trigger a crypto ‘arms race’ and reshape the global economic order Markets 25 Villains for ’25 AI Here’s our forecast for AI this year Markets How the CIA director helps the US navigate a world of spies, threats and geopolitical turbulence Climate Firefighting planes are dumping ocean water on the Los Angeles fires − why using saltwater is typically a last resort Climate LA fires: Why fast wildfires and those started by human activities are more destructive and harder to contain Market News 4 reasons why the US might want to buy Greenland – if it were for sale, which it isn’t Load more